The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Testosterone Suppresses Hepcidin in Men: A Potential Mechanism for Testosterone-Induced Erythrocytosis
Open accessAbstract
CONTEXT: The mechanisms by which testosterone increases hemoglobin and hematocrit are unknown. OBJECTIVE: The aim was to test the hypothesis that testosterone-induced increase in hematocrit is associated with suppression of the iron regulatory peptide hepcidin. PARTICIPANTS: Healthy younger men (ages 19-35 yr; n = 53) and older men (ages 59-75 yr; n = 56) were studied. METHODS: Weekly doses of testosterone enanthate (25, 50, 125, 300, and 600 mg) were administered over 20 wk, whereas endogenous testosterone was suppressed by monthly GnRH agonist administration. Blood and serum parameters from each individual were measured at wk 0, 1, 2, 4, 8, and 20. Longitudinal analyses were performed to examine the relationship between hepcidin, hemoglobin, hematocrit, and testosterone while controlling for potential confounders. RESULTS: High levels of testosterone markedly suppressed serum hepcidin within 1 wk. Hepcidin suppression in response to testosterone administration was dose-dependent in older men and more pronounced than in young men, and this corresponded to a greater rise in hemoglobin in older men. Serum hepcidin levels at 4 and 8 wk were predictive of change in hematocrit from baseline to peak levels. CONCLUSION: Testosterone administration is associated with suppression of serum hepcidin. Greater increases in hematocrit in older men during testosterone therapy are related to greater suppression of hepcidin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, testosterone fails to directly activate EPO transcription in Hep3B cells, an EPO-secreting cell line that is highly sensitive to hypoxic induction (11)”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [11]
Citations
Cites
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Self-citationTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Self-citationCalof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Self-citationImmunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688
Self-citationBhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1184 · Cited by 544
Self-citationEffects of graded doses of testosterone on erythropoiesis in healthy young and older men
Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1692 · Cited by 404
Self-citationIron Sequestration and Anemia of Inflammation
Ganz, T., & Nemeth, E. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.001 · Cited by 361
Self-citationProinflammatory state, hepcidin, and anemia in older persons
Ferrucci, L., Semba, R. D., Guralnik, J. M., Ershler, W. B., Bandinelli, S., Patel, K. V., Sun, K., Woodman, R. C., Andrews, N. C., Cotter, R. J., et al. (2010) · Blood · doi:10.1182/blood-2009-02-201087 · Cited by 245
Self-citationAndrogens and erythropoiesis: past and present
Shahani, S., Braga-Basaria, M., Maggio, M., & Basaria, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345745 · Cited by 231
Self-citation
Cited by
Sorted by citations
Items 201–247 of 247
ONOJA, R., Ogara, A. L., Ihedioha, J. I., & Shoyinka, S. V. O. (2023) · Sahel Journal of Veterinary Sciences · doi:10.54058/saheljvs.v20i1.343 · Cited by 1
Emejuo, N. T., Omeke, J. N., Onoja, R. I., Shoyinka, S. V. O., Ezema, A. S., & Ugwoke, S. N. (2025) · Comparative Clinical Pathology · doi:10.1007/s00580-025-03664-z · Cited by 1
Matsuoka, T., Tomita, H., Tagami, T., Maruyama, N., Yasuo, M., Nagura, C., Tsunemi, A., Nakamura, Y., Maruyama, T., Abe, M., et al. (2025) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.70040 · Cited by 1
Deruyver, Y., Gabriel, C., Debussche, S., Waterloos, M., Huybrechts, S., Dekuyper, P., Ameye, F., Dierick, J., & Baelen, A. V. (2020) · Urology · doi:10.1016/j.urology.2020.03.037 · Cited by 1
Testosterone-Secreting Ovarian Tumor: A Rare Cause of Erythrocytosis and Pulmonary Embolus
Friedman, N., Friedman, S. G., Klein, V. R., & Sternchos, J. A. (2020) · AACE Clinical Case Reports · doi:10.1016/j.aace.2020.11.029 · Cited by 1
Kareem, A. O., Akinbami, A. A., Uche, E. I., Suleiman, A. M., Bamiro, R. A., Augustine, B., Odebiyi, H. A., & Odunniyi, A. O. (2021) · International Journal of Scientific Reports · doi:10.18203/issn.2454-2156.intjscirep20214492 · Cited by 1
Iyer, R., & Handelsman, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_23 · Cited by 1
Vecchi, C., & Pietrangelo, A. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch29 · Cited by 1
Elliott, J. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5176
Testosterone replacement therapy
Vrolyk, M. (2015) · OpenBU (Boston University)
Chmiel-Majewska, K., Daniewska, D., Misiorowski, G., Zgliczyński, W., Gellert, R., & Jerzy, P. (2015)
Undecanoate in Routine Clinical Practice
Middleton, T. L., Turner, L., Fennell, C., Savkovic, S., Jayadev, V., Conway, A., & Handelsman, D. J. (2015)
Iyer, R., & Handelsman, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_19
Benefits and Adverses Effects of Testosterone Therapy
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_13
Frailty and anabolic hormones in ageing men
O’Connell, M. D. L. (2011) · Research Explorer (The University of Manchester)
Casale, M., Roberti, D., Mandato, C., Iorio, R. F., Caropreso, M., Scianguetta, S., Picariello, S., Perrotta, S., & Vajro, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-66586-6
Inoue, T. (2020) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.53.449
Iron, TIBC and Ferritin Levels Correlation with Testosterone Deficient Males in Dhaka, Bangladesh
Sarkar, A., Asaduzzaman, M., Juliana, F. M., Islam, M. J., Liza, M. Y. A., Das, B. C., Tanzid, M., Hosen, M. S., & Islam, M. T. (2020) · Journal of Health, Medicine and Nursing · doi:10.7176/jhmn/81-10
Erythrocytosis in Patients on Testosterone Therapy
Desai, A. P., & Go, R. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-77111-9_2
Benefits of Testosterone Treatment
Basaria, S. S., & Gagliano‐Jucá, T. (2022) · doi:10.1093/med/9780198870197.003.0489
Self-citationSex Steroid Actions in the Male
Vanderschueren, D., Antonio, L., Kim, N. R., & Claessens, F. (2022) · doi:10.1093/med/9780198870197.003.0481
Dhindsa, S. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch85
Anemia in the Elderly. A Review
Куликов, И. А., & Demikhov, V. G. (2022) · Гематология Трансфузиология Восточная Европа · doi:10.34883/pi.2022.8.1.004
Cobo, G., Gallar, P., Gioia, C. D., Lacalle, C. G., Camacho, R., Rodríguez, I., Ortega, O., Mon, C., Vigil, A., Lindholm, B., et al. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2016.12.008
Alfaro-Magallanes, V. M. (2022) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.71841
Bromińska, B., Sawicka‐Gutaj, N., Szczepanek‐Parulska, E., Krygier, A., Olejarz, M., & Ruchała, M. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16488
Al-Obaidi, W. M. L. (2023) · Journal of the faculty of Education · doi:10.60037/edu.v1i15.1202
Benefits and Adverse Events of Testosterone Therapy
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_16
Vor- und Nachteile der Testosterontherapie
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_16
Missbrauch und Missbrauch von Testosteron
Iyer, R., & Handelsman, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_23
Reproductive and nonreproductive actions of testosterone
Gagliano‐Jucá, T., Jain, A., Jasuja, R., & Bhasin, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00198-9
Self-citationHypogonadism in Men with Obesity and Type 2 Diabetes
Dhindsa, S., Ghanim, H., & Dandona, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_18
Iron-Deficiency Anemia Associated With Prostate Cancer, and Ameliorated by Anti-androgen Therapy
Takenaka, T., Ozu, C., Oshiba, Y., Kawakami, Y., & Okuda, M. (2025) · Cureus · doi:10.7759/cureus.88150
Alanazi, F., Abdulwahed, A., Alshuweishi, Y., Farzan, R. A., Almuqrin, A., AlSudais, H., Aljasham, A. T., Alrashed, M. M., Alanazi, A. T., & Alshalani, A. (2025) · Research Square · doi:10.21203/rs.3.rs-7142446/v1
Conduite à tenir devant une polyglobulie
Rivière, É., & Viallard, J. (2026) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2025.12.008
Ma, C., Guan, L., Chen, Q., Cheng, R., Wu, W., & Qiu, L. (2026) · Diagnostics · doi:10.3390/diagnostics16060944
Čeponis, J., Wang, C., Swerdloff, R., & Liu, P. Y. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-2
Yamazaki, S., Onda, K., & Masuyama, K. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1791198
Male sex and iron deficiency risk at 6 months: the mediating role of rapid weight gain
Ge, D., Nie, J., Shi, Y., Li, C., Li, W., & Liu, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1829613
Silva, K. O. A. E., & Spini, V. B. M. G. (2026) · Research Society and Development · doi:10.33448/rsd-v15i4.50924
Maconyte, V., Stasiulė, L., & Stasiulis, A. (2026) · Sports · doi:10.3390/sports14050192
Iron, autoimmunity, and thrombosis: Exploring sex-specific interactions
Gualtierotti, R., & Valenti, L. V. C. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104101
Voinea, R.-A., Ronger, L., Martínez, A., & Tauveron, I. (2026) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(26)64729-1
Jiesisibieke, Z. L., & Schooling, C. M. (2026) · The Aging Male · doi:10.1080/13685538.2026.2717455
Voinea, R.-A., Ronger, L., Martínez, A., & Tauveron, I. (2026) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(26)52261-x
Metadata
- Authors
- Bachman, E., Feng, R., Travison, T., Li, M., Olbina, G., Ostland, V., Ulloor, J., Zhang, A., Basaria, S., Ganz, T., Westerman, M., & Bhasin, S.
- Affiliations
- Boston University (US)
- University of Pennsylvania (US)
- Intrinsic LifeSciences (United States) (US)
- University of California, Los Angeles (US)
- Corresponding author
- Bachman, Eric
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-10
- Volume
- 95
- Issue
- 10
- Pages
- 4743-4747
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3050108
- OpenAlex
- W2150542348
- Cited by
- 247
- References
- 19
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 9 · 2023: 16 · 2022: 16 · 2021: 11 · 2020: 23 · 2019: 15 · 2018: 13 · 2017: 18 · 2016: 12 · 2015: 20 · 2014: 15 · 2013: 20 · 2012: 16
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Boston University
- Evans Medical Foundation
- National Institutes of Health (5p30ag031679-15)
- National Institute on Aging (U01AG014369, U01 AG14369, P30-AG031679)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- testosterone, hepcidin, testosterone enanthate, hematocrit, hemoglobin, iron regulation, GnRH agonist suppression, dose-response relationship, age differences, men
- MeSH terms
- Adult, Aged, Aging, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Humans, Injections, Male, Middle Aged, Polycythemia, Testosterone, Down-Regulation, Leuprolide, Antimicrobial Cationic Peptides, Young Adult, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review